Acciones Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Acciones
IL0006290147
Farmacéuticos
Ventas 2024 * | 15,86 mil M 6.039000 M 14,84 mil M | Ventas 2025 * | 16,35 mil M 6.223000 M 15,29 mil M | Capitalización | 15,64 mil M 5.955000 M 14,63 mil M |
---|---|---|---|---|---|
Resultado Neto 2024 * | 1538 M 586 mil M 1438,43 M | Resultado Neto 2025 * | 1442 M 549 mil M 1348,65 M | VE / Ventas 2024 * | 1,91 x |
Deuda neta 2024 * | 14,62 mil M 5.567000 M 13,68 mil M | Deuda neta 2025 * | 12,12 mil M 4.613000 M 11,33 mil M | VE / Ventas 2025 * | 1,7 x |
P/E ratio 2024 * |
11,1
x | P/E ratio 2025 * |
10,3
x | Empleados | - |
Rendimiento 2024 * |
-
| Rendimiento 2025 * |
-
| Flotante | 89,71 % |
Último transcript sobre Teva Pharmaceutical Industries Limited
Directores | Puesto | Edad | Desde |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01/01/23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22/12/19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01/09/15 |
Janet Vergis
BRD | Director/Board Member | 60 | 09/06/20 |
Sol Barer
CHM | Chairman | 76 | 01/01/15 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+25,83 % | 661 mil M | |
+27,00 % | 566 mil M | |
-6,76 % | 352 mil M | |
+20,34 % | 332 mil M | |
+3,00 % | 283 mil M | |
+13,09 % | 231 mil M | |
+5,46 % | 200 mil M | |
-9,61 % | 195 mil M | |
-6,26 % | 145 mil M |